4Bergogne - Berezin E . Guideline on antimicrobial chemotherapy for prevention and treatment of infections in the ICU. J Chemother,2001,13 : 134 ～ 149.
5Performance standards for antimicrobial susceptibility testing. Appoved standard M2-A8. National Committee for Clinical Laboratory Standards,2003.
6Venezia R A, Damaracki B E, Erans A M, et al. Selection of high-level oxacillin resistance in heteroresistant staphylococcus aureus by fluoroquinolone exposure. J Antimicrob Chemother, 2001,48 : 357 ～ 381.
7Performance standards for antimicrobial susceptibility testing. Appoved standard M100-S13. National Committee for Clinical Laboratory Standards, 2003.
8Ohya S,Fukuoka T,Masuda N,et al.Microbiological evaluation of panipenem/betamipron,a new parenterally active carlapenem V.increase in susceptibility of pseudomonas aeruginosa to panipenem in low.amino-acid media.Chemo Therapy,1991,39(S-3):132
9Levy SB.The Challenge of antibiotic resistance[J].Scientific American,1998,278:46-53
10Jones RN,Pfaller MA.Bacterial resistance: A worldwide problem[J].Diagn.Microbiol Infect Dis,1998,31:379-388
